Medikine
1 known investors
Medikine engineers cytokine mimetics — peptide-based therapeutics that mimic natural cytokines — to treat serious diseases, with a focus on immuno-oncology. The company develops optimized therapies based on cytokine mimesis for clinical use.
Founders & leadership
WJ
William J. DowerPhD
MC
Michael C. NeedelsPhD
RW
Ronald W. BarrettPhD
JL
Joseph LevequeMD, CEO
Investors · 1
Frequently asked questions
- What does Medikine do?
- Medikine engineers cytokine mimetics — peptide-based therapeutics that mimic natural cytokines — to treat serious diseases, with a focus on immuno-oncology. The company develops optimized therapies based on cytokine mimesis for clinical use.
- Who founded Medikine?
- Medikine was founded by William J. Dower, Michael C. Needels, Ronald W. Barrett.
- Who are Medikine's investors?
- Medikine's investors include Bluebird Ventures.